breast cancer

Original Research

Measuring Biomechanical Properties Using a Noninvasive Myoton Device for Lymphedema Detection and Tracking: A Pilot Study

11/10/2022

Shelia Ridner , RN, PhD;

Antonio Jorge Forte , MD, PhD;

Patrick E. Assi , MD;

Salam Al Kassis , MD;

Galen Perdikis , MD;

Gabriella E. Glassman , MD;

Laura Dellalana , MD;

Eric R. Tkaczyk , MD, PhD;

Isaac Manzanera Esteve , PhD;

Joyce Yongxu Huang , MD, PhD;

Austin Cronin , BS;

J. Randall Patrinely , MD;

Shervin Etemad , MD;

This study aims to use the noninvasive MyotonPRO Device to detect differences in biomechanical skin characteristics in patients with breast cancer–related lymphedema.

This study aims to use the...

11/10/2022

ePlasty

Figure 1. PRISMA flow diagram for study selection.

Review

Surgical Lymphedema Treatment: A Meta-Analysis and Recommendations

11/02/2022

Christopher Homsy , MD;

Magnus J. Chun , BS;

Fouad Saeg , MD;

Derek Miller , BS;

Christina Jardak , MD;

Angela Sultan , MS;

Abby B Duplechain , BS ;

This meta-analysis evaluates the outcomes of common surgical treatments of lymphedema and provides suggestions for future research directions. The findings indicate that lymphaticovenous anastomosis is neither superior nor inferior to...

This meta-analysis evaluates the...

11/02/2022

ePlasty

Pearls for Practice

Comfort and Closure: A New Perspective on the Treatment of Fungating Breast Wounds and Use of a Hypochlorous Acid–Preserved Wound Cleanser

10/04/2021

Amanda Murray , NP-C, BSN, WCC;

Three case reports in the hospital-based outpatient wound care setting demonstrate how a hypochlorous acid–preserved wound cleanser was used, synergistically with other wound care modalities, to achieve a significant reduction in wound...

Three case reports in the...

10/04/2021

Wound Management & Prevention

Evidence Corner

Surgical Site Infection in Cancer Patients

10/01/2021

Laura Bolton

This Evidence Corner, which includes 2 studies, clarifies evidence supporting the use of recognized preoperative antibiotic administration to support host defenses in patients undergoing breast cancer surgery.

This Evidence Corner, which...

10/01/2021

Wounds

News

No Survival Benefit with Celecoxib versus Placebo for ERBB2-negative Primary Breast Cancer

08/24/2021

Adjuvant celecoxib offered no disease-free survival benefit compared to placebo in patients with unselected ERBB2-negative primary breast cancer.

Adjuvant celecoxib offered no...

08/24/2021

Oncology

Anthony Lucci, MD, The University of Texas MD Anderson Cancer Center

Videos

Top Advancements in Breast Cancer Care: What Can We Expect in the Next 5 Years?

08/16/2021

Anthony Lucci, MD, highlights 5 developments in breast cancer care he believes we will see come to fruition within the next 5 years.

Anthony Lucci, MD, highlights 5...

08/16/2021

Oncology

Single-stage Extremity Reconstruction through the Use of Acellular Dermal Matrices: the Power of Dermal Matrices in the Face of Patient Preference or Extreme Non-compliance

The use of acellular dermal matrices (ADMs) in extremity reconstruction often involve two-stage reconstruction. Two-stage procedures are generally conducted on patients with large defects...

Rebecca Gold ;

Maci Pfaffenbeger ;

Davi Mayer ;

Jessica Nelson ;

11/23/2020